Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-05-005247
Filing Date
2005-03-16
Accepted
2005-03-16 16:36:30
Documents
4
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f06585e10vk.htm 10-K 727190
2 EXHIBIT 23.1 f06585exv23w1.htm EX-23.1 3836
3 EXHIBIT 31.1 f06585exv31w1.htm EX-31.1 7272
4 EXHIBIT 32.1 f06585exv32w1.htm EX-32.1 4871
  Complete submission text file 0000950134-05-005247.txt   745037
Mailing Address 2100 POWELL STREET EMERYVILLE CA 94608
Business Address 2100 POWELL STREET EMERYVILLE CA 94608 5105976500
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28298 | Film No.: 05685941
SIC: 2836 Biological Products, (No Diagnostic Substances)